Platelet-rich plasma in tendinopathies: Current evidence and limits of indication

Platelet-rich plasma (PRP) has been proposed as a biologic treatment for symptomatic tendinopathy, yet its clinical use has expanded faster than evidence of an additional benefit over adequately controlled care. This critical narrative review examines the comparative effectiveness of PRP, identifies sources of disagreement between trials, and defines defensible limits to its indication across major tendon sites. Relevant randomized studies, systematic reviews, and clinical practice guidelines were examined through PubMed-indexed literature, Cochrane publications, and professional society sources available up to 2026. For chronic midportion Achilles tendinopathy, larger sham-controlled studies and an updated meta-analysis do not demonstrate clinically important improvements. Similarly, placebo-controlled findings for lateral elbow and patellar tendinopathy do not justify routine use. Rotator cuff recommendations discourage PRP as a first-line strategy or routine injection, despite some positive small trials. A potentially favorable signal in gluteal tendinopathy derives largely from comparisons with corticosteroid, not sham treatment, and must be interpreted alongside evidence supporting education and exercise. Preparation variability, co-interventions, limited long-term safety reporting, and weak identification of responders restrict generalizability. PRP remains a selective, preference-sensitive option in narrowly defined circumstances, not a substitute for progressive loading or a validated method of tendon regeneration.

Authors

Institutions

Publication Details

Journal
International Health Sciences Review
Published
2026-11-13
DOI
https://doi.org/10.70164/ihsr.v2i6.269
Primary Topic
Tendon Structure and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Platelet-rich plasma in tendinopathies: Current evidence and limits of indication

Eduardo Moreschi, Matheus Bovolim Lourenço, Guilherme Böhm Ferreira, Rômulo Demamam Bersch et al.
International Health Sciences Review
Tendon Structure and Treatment
article

Platelet-rich plasma in tendinopathies: Current evidence and limits of indication

Eduardo Moreschi, Matheus Bovolim Lourenço, Guilherme Böhm Ferreira, Rômulo Demamam Bersch, ANTONIO ANDREI PINHO BRAGA, Rafael de Souza Pinto Paiva Diniz, Luana Alberton Medeiros, Vallentina Paraboni Frandoloso, Milena Rizzo, Maria Paula Ferreira Santos, Arthur Schmidt Strelow
article en

Abstract

Platelet-rich plasma (PRP) has been proposed as a biologic treatment for symptomatic tendinopathy, yet its clinical use has expanded faster than evidence of an additional benefit over adequately controlled care. This critical narrative review examines the comparative effectiveness of PRP, identifies sources of disagreement between trials, and defines defensible limits to its indication across major tendon sites. Relevant randomized studies, systematic reviews, and clinical practice guidelines were examined through PubMed-indexed literature, Cochrane publications, and professional society sources available up to 2026. For chronic midportion Achilles tendinopathy, larger sham-controlled studies and an updated meta-analysis do not demonstrate clinically important improvements. Similarly, placebo-controlled findings for lateral elbow and patellar tendinopathy do not justify routine use. Rotator cuff recommendations discourage PRP as a first-line strategy or routine injection, despite some positive small trials. A potentially favorable signal in gluteal tendinopathy derives largely from comparisons with corticosteroid, not sham treatment, and must be interpreted alongside evidence supporting education and exercise. Preparation variability, co-interventions, limited long-term safety reporting, and weak identification of responders restrict generalizability. PRP remains a selective, preference-sensitive option in narrowly defined circumstances, not a substitute for progressive loading or a validated method of tendon regeneration.

International Health Sciences ReviewVol. 2(6)
Univates (BR), Universidade de Taubaté (BR), Universidade Feevale (BR), Centro Universitário Cesumar (BR), Centro Universitário Capital (BR), Atitus Educação (BR), Universidade do Vale do Rio dos Sinos (BR), Universidade do Extremo Sul Catarinense (BR)
Good health and well-being
Tendon Structure and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon